Actions and Detail Panel
Annual Insulin Potentiation Therapy (IPT) Conference: Munich, Germany. Octo...
Sat, Oct 14, 2017, 8:30 AM – Sun, Oct 15, 2017, 1:00 PM CEST
Insulin Potentiation Therapy (IPTLD®) is a medical protocol in which the hormone insulin is used as a pharmacologic adjunct to potentiate the effects of commonly used allopathic medications. It can be used in several chronic degenerative diseases including cancer: it is a metabolic supported chemotherapy as It involves fasting, insulin and chemotherapy.
This is our 17th year of continuos training and education focusing on IPT. This year, 2017, the focus will be on managing Lyme Disease. From establishing diagnosis to an effective treatment.
- Who: Practitioners of all backgrounds looking to practice or to provide patient education on new ways for the care of cancer and other chronic diseases
- Where: Le Méridien, Bayerstrasse 41, Munich 80335 Germany
- When: Saturday October 14, 2017 - Sunday October 15, 2017
- What: Education from international contributors in innovative ways of managing Lyme disease and cancer through the application of Insulin Potentiation Therapy (IPT)
Saturday and Sunday October 14 – 15, 2017.
This year’s agenda will be divided between presentations on the application of IPT for Lyme (Sunday October 15) and IPT and other supportive treatments in the palliation of cancer-related symptoms such as pain, swelling, and discomfort (Saturday October 14, 2017.
The Academy for IPT/IPTLD® is the official professional organization of IPT/IPTLD® physicians and was established to oversee the ethical, professional, scientific and business related development of IPT/IPTLD® within each member’s respective community and our global society at large. The intention of the Academy is to assure that IPT/IPTLD® is taught and practiced with knowledge and ethics and that all physicians involved are afforded the sharing of solid experience tempered with innovative excellence and that physicians are kept abreast in precise IPT methodology and scientific advancements. The sole purpose is to disseminate accurate, updated knowledge, insure excellence of practice and promise the sharing of continued scientific advancement.
The Academy for IPT/IPTLD® is interested in a solid holistic and integrated platform of healing and strengthening components: mind, body, spirituality, diet, nutrition, detoxification, immune system health and exercise, to support and strengthen the patient’s body to further increase the effectiveness of Insulin Potentiation Targeted Low Dose Therapy or IPTLD® as a targeted cancer therapy to destroy the cancer, not the patient.
The Academy for IPT/IPTLD® works along the lines of the inventor, the establisher, the founder and professor. As you know it was Donato Perez Garcia, MD (1896-1971) who invented “Insulin Potentiation Therapy” or IPT/IPTLD® in 1930. The inventor taught IPT to his son, Donato Perez Garcia y Bellon, MD (1930-2000) who become an IPT Master and he taught and passed his IPT expertise on to Donato Perez Garcia, MD.
The Academy for IPT/IPTLD® extends an invitation to those medical professionals, worldwide, who are interested in uniting under an International Academy for IPT focused on IPT/IPTLD® and continue to strive toward excellence in education, sharing scientific and practical advancements.
Official training on Insulin Potentiation therapy IPT or IPTLD is currently offered only by Donato Perez Garcia, MD.
Dr. Donato Perez Garcia holds the legal rights by means of © Copyright on the manuals and training materials on IPT/IPTLD and owns IPTLD® Trademark.
Interested in learning IPT/IPTLD, recertification on IPT/IPTLD or attending an update workshop email: firstname.lastname@example.org